SUPN Historical PE Ratio image   This SUPN PE ratio history page last updated 11/6/2024
SUPN PE History Chart
PeriodPriceGAAPTTMPE
Q3 2024
11/4/2024
34.700.691.4424.1
Q2 2024
8/6/2024
27.880.360.4660.6
Q1 2024
5/8/2024
31.300.000.08391.2
Q4 2023
2/27/2024
30.690.390.3782.9
Q3 2023
11/8/2023
23.52-0.290.4157.4
Q2 2023
8/8/2023
32.91-0.020.7345.1
Q1 2023
5/9/2023
36.180.290.8940.7
Q4 2022
2/28/2023
37.590.431.0336.5
Q3 2022
11/8/2022
34.700.030.6454.2
Q2 2022
8/4/2022
32.810.140.6153.8
Q1 2022
5/9/2022
26.370.430.8730.3
Q4 2021
4/13/2022
32.630.040.8737.5
Q3 2021
11/3/2021
30.030.401.5119.9
Q2 2021
8/4/2021
27.180.431.8514.7
Q1 2021
5/5/2021
30.490.112.0714.7
Q4 2020
2/25/2021
29.450.572.3612.5
Q3 2020
11/3/2020
18.150.742.417.5
Q2 2020
8/18/2020
25.050.652.2111.3
Q1 2020
5/5/2020
22.170.402.1710.2
Q4 2019
2/25/2020
22.940.622.1110.9
Q3 2019
11/5/2019
29.130.541.9714.8
Q2 2019
8/6/2019
33.300.611.9517.1
Q1 2019
5/7/2019
36.960.341.9119.4
Q4 2018
2/26/2019
36.880.482.0617.9
Q3 2018
11/6/2018
41.650.522.0220.6
Q2 2018
8/7/2018
53.350.571.7929.8
Q1 2018
5/8/2018
44.650.491.5429.0
Q4 2017
2/27/2018
38.100.441.2430.7
Q3 2017
11/6/2017
41.100.291.0638.8
Q2 2017
8/2/2017
40.600.321.1435.6
Q1 2017
5/9/2017
32.900.191.0032.9
Q4 2016
2/28/2017
25.700.260.8928.9
Q3 2016
1/20/2017
23.450.370.7730.5
Q2 2016
8/2/2016
22.260.180.4846.4
Q1 2016
5/3/2016
16.540.080.3350.1
Q4 2015
3/2/2016
13.370.140.2749.5
Q3 2015
11/3/2015
17.780.080.2184.7
Q2 2015
8/4/2015
21.260.030.5240.9
Q1 2015
5/5/2015
12.540.020.5722.0
Q4 2014
3/10/2015
9.930.080.1758.4
Q3 2014
11/11/2014
7.910.39-0.56NA
Q2 2014
8/11/2014
8.330.08-1.73NA
Q1 2014
5/5/2014
7.98-0.38-2.70NA
Q4 2013
3/12/2014
9.15-0.65-2.92NA
Q3 2013
11/12/2013
6.90-0.78-2.78NA
Q2 2013
8/13/2013
6.24-0.89NANA
Q1 2013
5/13/2013
5.12-0.60NANA
Q4 2012
3/14/2013
6.90-0.51NANA
SUPN Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2024
11/4/2024
34.700.692.7612.6
Q2 2024
8/6/2024
27.880.361.4419.4
Q1 2024
5/8/2024
31.300.000.00NA
Q4 2023
2/27/2024
30.690.391.5619.7
Q3 2023
11/8/2023
23.52-0.29-1.16NA
Q2 2023
8/8/2023
32.91-0.02-0.08NA
Q1 2023
5/9/2023
36.180.291.1631.2
Q4 2022
2/28/2023
37.590.431.7221.9
Q3 2022
11/8/2022
34.700.030.12289.2
Q2 2022
8/4/2022
32.810.140.5658.6
Q1 2022
5/9/2022
26.370.431.7215.3
Q4 2021
4/13/2022
32.630.040.16203.9
Q3 2021
11/3/2021
30.030.401.6018.8
Q2 2021
8/4/2021
27.180.431.7215.8
Q1 2021
5/5/2021
30.490.110.4469.3
Q4 2020
2/25/2021
29.450.572.2812.9
Q3 2020
11/3/2020
18.150.742.966.1
Q2 2020
8/18/2020
25.050.652.609.6
Q1 2020
5/5/2020
22.170.401.6013.9
Q4 2019
2/25/2020
22.940.622.489.2
Q3 2019
11/5/2019
29.130.542.1613.5
Q2 2019
8/6/2019
33.300.612.4413.6
Q1 2019
5/7/2019
36.960.341.3627.2
Q4 2018
2/26/2019
36.880.481.9219.2
Q3 2018
11/6/2018
41.650.522.0820.0
Q2 2018
8/7/2018
53.350.572.2823.4
Q1 2018
5/8/2018
44.650.491.9622.8
Q4 2017
2/27/2018
38.100.441.7621.6
Q3 2017
11/6/2017
41.100.291.1635.4
Q2 2017
8/2/2017
40.600.321.2831.7
Q1 2017
5/9/2017
32.900.190.7643.3
Q4 2016
2/28/2017
25.700.261.0424.7
Q3 2016
1/20/2017
23.450.371.4815.8
Q2 2016
8/2/2016
22.260.180.7230.9
Q1 2016
5/3/2016
16.540.080.3251.7
Q4 2015
3/2/2016
13.370.140.5623.9
Q3 2015
11/3/2015
17.780.080.3255.6
Q2 2015
8/4/2015
21.260.030.12177.2
Q1 2015
5/5/2015
12.540.020.08156.8
Q4 2014
3/10/2015
9.930.080.3231.0
Q3 2014
11/11/2014
7.910.391.565.1
Q2 2014
8/11/2014
8.330.080.3226.0
Q1 2014
5/5/2014
7.98-0.38-1.52NA
Q4 2013
3/12/2014
9.15-0.65-2.60NA
Q3 2013
11/12/2013
6.90-0.78-3.12NA
Q2 2013
8/13/2013
6.24-0.89-3.56NA
Q1 2013
5/13/2013
5.12-0.60-2.40NA
Q4 2012
3/14/2013
6.90-0.51-2.04NA
Quotes delayed 20 minutes

Email EnvelopeFree SUPN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Supernus Pharmaceuticals (SUPN) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

SURF PE Ratio History
SVRA PE Ratio History
SWAV PE Ratio History
SWTX PE Ratio History
SYBX PE Ratio History
SYK PE Ratio History
SYNH PE Ratio History
SYRE PE Ratio History
SYRS PE Ratio History
TALS PE Ratio History
On this page we presented the SUPN PE Ratio History information for Supernus Pharmaceuticals' stock. The average SUPN PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 43.5. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average SUPN PE ratio history based on this TTM earnings result method is 42.9. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this SUPN PE ratio history result, against the recent PE: when this page was posted on 11/5/2024, the most recent closing price for SUPN had been 34.74, and the most recent quarterly earnings result, annualized, was 2.76. Meanwhile, the most recent TTM earnings summed to 1.44. From these numbers, we calculate the recent SUPN PE on 11/5/2024 based on annualized quarterly EPS was 12.6. Based on SUPN's history, that recent PE is low relative to the historical average, with the recent PE 71.0% lower than the historical average PE across our data set for Supernus Pharmaceuticals. Looking at the recent SUPN PE on 11/5/2024 based on TTM EPS, we calculate the ratio at 24.1. Based on SUPN's history, that recent PE is low relative to the historical average, with the recent PE 43.8% lower than the average PE across our Supernus Pharmaceuticals data set with TTM EPS used in the calculation at each period.

Another interesting SUPN PE ratio history calculation we look at is to take the median earnings per share of the last four quarters for SUPN, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for SUPN, we start with the past four EPS numbers and we first sort them from lowest to highest: 0.00, 0.36, 0.39, and 0.69. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.36 and 0.39 — which gives us the median of 0.38. Basically the way to think about this 0.38 number is this: for the trailing four earnings reports, 0.38 marks the "middle ground" number where SUPN has reported a value higher than 0.38 half the time, and has reported a value lower than 0.38 half the time. Annualizing that median value then gets us to 1.52/share, which we use as the denominator in our next PE calculation. With 34.74 as the numerator (as of 11/5/2024), the calculation is then 34.74 / 1.52 = 22.9 as the SUPN PE ratio as of 11/5/2024, based on that annualized median value we calculated.

For self directed investors doing their due diligence on SUPN or any other given stock, valuation analysis for SUPN can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Supernus Pharmaceuticals PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for SUPN. Thanks for visiting, and the next time you need to research SUPN PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: Funds Holding LOAC, Top Ten Hedge Funds Holding GMFS, Institutional Holders of ESBF.

 

SUPN PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.